7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%

Agrium Slips to Neutral

by Zacks Equity Research

December 05, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We are downgrading our recommendation on leading fertilizer company Agrium Inc. ( AGU - Analyst Report ) to Neutral factoring in its weak fourth quarter outlook. The company posted tepid third-quarter 2012 results with adjusted earnings of $1.11 per share trailing the Zacks Consensus Estimate of $1.81. Its profit slid 56% year over year on weak potash demand.

Revenues fell roughly 6% year over year to $2,962 million, also falling behind the Zacks Consensus Estimate of $3,094 million. The company saw lower sales across its Retail and Wholesale segments in the quarter.

Retail sales dipped 9% as early harvest and severe drought conditions in the U.S. hurt demand for some crop inputs products. Wholesale segment revenues declined 3% due to the downtime at the company’s Vanscoy potash facility.

Agrium stands to gain from rising crop prices and overall strong fundamentals for the agriculture and crop input market. The company follows a strategy to grow along the value chain through a combination of acquisitions and organic development.

The acquisition of AWB has expanded Agrium’s Retail division and provided access to the growing Southeast Asia market. Moreover, the acquisition of Viterra’s agri-products business is expected to support its earnings in 2013.

The company expects high crop prices and tight grain inventories to create higher demand for its nutrients. It envisions strong demand for top quality seeds in the 2013 growing season. Agrium is also expected to benefit from healthy demand for urea in India and Brazil.

However, weak overseas potash demand stemming from the uncertainty associated with new supply contracts with China and India is impacting pricing for the nutrient and is expected to significantly affect overseas shipment volumes in the fourth quarter.

Results in the fourth quarter are expected to be lower compared with the year-ago quarter as the company anticipates a significant decline in international potash demand and lower ammonia sales in Western Canada due to unfavorable weather conditions. Moreover, global phosphate market is expected to remain weak in the near term, partly due to lower demand from India.

Agrium, which competes with CF Industries Holdings Inc. ( CF - Analyst Report ) and Potash Corp. of Saskatchewan Inc. ( POT - Analyst Report ) , retains a short-term (1 to 3 months) Zacks #3 Rank (Hold).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.